UBS Group
EVOJW

UBS Group’s Evo Acquisition Corp. Warrant EVOJW Stock Holding History

UBS Group’s Portfolio EVOJW Stock Details EVOJW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-308
Closed – – 11508
2022
Q3 		$0 Hold
308
– – ﹤0.01% 11417
2022
Q2 		$0 Sell
308
-210
-41% -$35 ﹤0.01% 11402
2022
Q1 		$0 Hold
518
– – ﹤0.01% 11286
2021
Q4 		$0 Buy
518
+350
+208% +$194 ﹤0.01% 11026
2021
Q3 		$0 Buy
+168
New +$108 ﹤0.01% 10389

Other funds holding EVOJW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
UFM
Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return

UBS Group's EVOJW Position: Q4 2022 in Review

UBS Group sold out of Evo Acquisition Corp. Warrant (EVOJW) in Q4 2022, closing a stake of 308 shares.

UBS Group first reported a position in EVOJW in Q3 2021 and held it in 5 quarters. The position peaked at $0 in Q3 2022. 39 funds tracked by Wall St. Rank hold EVOJW as of Q4 2022.

  • UBS Group reported no remaining Evo Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 308 Evo Acquisition Corp. Warrant shares in Q4 2022.
  • UBS Group first reported a position in Evo Acquisition Corp. Warrant in Q3 2021 and held it in 5 quarters.
  • UBS Group's Evo Acquisition Corp. Warrant position peaked at $0 in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Evo Acquisition Corp. Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.